VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS

沙眼衣原体感染疫苗

• 批准号: 7959090
• 负责人: LUIS M DE LA MAZA
• 金额: $ 3.56万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7959090
• 关键词: California; Chlamydia trachomatis; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Human; Immune response; Infection; Institution; Macaca mulatta; Modeling; Primates; Proteins; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Vaccines; nonhuman primate; preclinical study

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objective of this project is to demonstrate that Chlamydia trachomatis proteins stimulate vigorous immune responses in immunized rhesus macaques. This is a pre-clinical study in a nonhuman primate model with direct translational relevance to studies in humans.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 该项目的目的是证明沙眼衣原体蛋白会刺激免疫恒河猕猴中剧烈的免疫反应。 这是在非人类灵长类动物模型中进行的临床前研究，该模型与人类研究直接转化相关。